UNBSF
Uni-Bio Science Group Limited, an investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People's Republic of China. It operates through Chemical Pharmaceutical Products, Biological Pharmaceutical Products, and Pipeline Products segments. The company provides BOGUTAI, a disposable injection pen fo… Read more
UNBSF (UNBSF) - Total Assets
Latest total assets as of June 2025: $556.05 Million USD
Based on the latest financial reports, UNBSF (UNBSF) holds total assets worth $556.05 Million USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
UNBSF - Total Assets Trend (2020–2024)
This chart illustrates how UNBSF’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
UNBSF - Asset Composition Analysis
Current Asset Composition (December 2024)
UNBSF's total assets of $556.05 Million consist of 61.6% current assets and 38.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 12.6% |
| Accounts Receivable | $54.79 Million | 10.6% |
| Inventory | $33.78 Million | 6.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $42.86 Million | 8.3% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2020–2024)
This chart illustrates how UNBSF's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: UNBSF's current assets represent 61.6% of total assets in 2024, a decrease from 71.8% in 2020.
- Cash Position: Cash and equivalents constituted 12.6% of total assets in 2024, up from 9.9% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, an increase from 6.0% in 2020.
- Asset Diversification: The largest asset category is accounts receivable at 10.6% of total assets.
UNBSF Competitors by Total Assets
Key competitors of UNBSF based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
UNBSF - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - UNBSF generates 1.07x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, UNBSF generates $ 15.99 in net profit.
UNBSF - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.40 | 2.50 | 2.47 |
| Quick Ratio | 3.22 | 2.17 | 2.04 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $241.43 Million | $ 178.04 Million | $ 118.56 Million |
UNBSF - Advanced Valuation Insights
This section examines the relationship between UNBSF's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.59 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | 26.2% |
| Total Assets | $517.55 Million |
| Market Capitalization | $12.45 Million USD |
Valuation Analysis
Below Book Valuation: The market values UNBSF's assets below their book value (0.02 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: UNBSF's assets grew by 26.2% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for UNBSF (2020–2024)
The table below shows the annual total assets of UNBSF from 2020 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $517.55 Million | +26.23% |
| 2023-12-31 | $409.99 Million | +40.18% |
| 2022-12-31 | $292.47 Million | +9.30% |
| 2021-12-31 | $267.59 Million | +5.89% |
| 2020-12-31 | $252.72 Million | -- |